Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

16397 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Research Grade Andecaliximab Biosimilars Andecaliximab Hu ANSY-DHD06801-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Elgemtumab Biosimilars Elgemtumab Hu Human ANSY-DHD48401-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Lumretuzumab Biosimilars Lumretuzumab Hu ANSY-DHD48402-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Duligotuzumab Biosimilars Duligotuzumab Hu ANSY-DHD48403-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Patritumab Biosimilars Patritumab Hu Human ANSY-DHD48404-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Seribantumab Biosimilars Seribantumab Hu Human ANSY-DHD48405-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Emibetuzumab Biosimilars Emibetuzumab Hu ANSY-DHC34201-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Onartuzumab Onartuzumab Hu ANSY-DHC34202-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Telisotuzumab Biosimilars Telisotuzumab Hu ANSY-DHC34203-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Abagovomab Biosimilars Abagovomab Hu Mouse ANSY-DHJ31001-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Igovomab Igovomab Hu Mouse ANSY-DHJ31002-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Oregovomab Biosimilars Oregovomab Hu Mouse ANSY-DHJ31003-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Sofituzumab Biosimilars Sofituzumab Hu ANSY-DHJ31004-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Demcizumab Biosimilars Demcizumab Hu ANSY-DHJ65301-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Enoticumab Biosimilars Enoticumab Hu Human ANSY-DHJ65302-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Navicixizumab Navicixizumab Hu ANSY-DHJ65303-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Dilpacimab Dilpacimab Hu ANSY-DHJ65304-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Farletuzumab Biosimilars Farletuzumab Hu ANSY-DHD10401-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Mirvetuximab Biosimilars Mirvetuximab Hu ANSY-DHD10402-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Indusatumab Biosimilars Indusatumab Hu Human ANSY-DHD65601-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Anetumab Biosimilars Anetumab Hu Human ANSY-DHG52001-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Amatuximab Biosimilars Amatuximab Hu ANSY-DHG52002-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Enapotamab Biosimilars Enapotamab Hu Human ANSY-DHD89501-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Tilvestamab Biosimilars Tilvestamab Hu ANSY-DHD89502-1mg

AntibodySystem
1 mg Login
Compare
Research Grade Pasotuxizumab Pasotuxizumab Hu ANSY-DHG01301-1mg

AntibodySystem
1 mg Login
Compare
Name Price
Research Grade Andecaliximab Login
Type Biosimilars
Clone Andecaliximab
Specific against Hu
Appl.
Host
Item no.
Amount 1 mg
Available
Research Grade Elgemtumab Login
Type Biosimilars
Clone Elgemtumab
Specific against Hu
Appl.
Host Human
Item no.
Amount 1 mg
Available
Research Grade Lumretuzumab Login
Type Biosimilars
Clone Lumretuzumab
Specific against Hu
Appl.
Host
Item no.
Amount 1 mg
Available
Research Grade Duligotuzumab Login
Type Biosimilars
Clone Duligotuzumab
Specific against Hu
Appl.
Host
Item no.
Amount 1 mg
Available
Research Grade Patritumab Login
Type Biosimilars
Clone Patritumab
Specific against Hu
Appl.
Host Human
Item no.
Amount 1 mg
Available
Research Grade Seribantumab Login
Type Biosimilars
Clone Seribantumab
Specific against Hu
Appl.
Host Human
Item no.
Amount 1 mg
Available
Research Grade Emibetuzumab Login
Type Biosimilars
Clone Emibetuzumab
Specific against Hu
Appl.
Host
Item no.
Amount 1 mg
Available
Research Grade Onartuzumab Login
Type
Clone Onartuzumab
Specific against Hu
Appl.
Host
Item no.
Amount 1 mg
Available
Research Grade Telisotuzumab Login
Type Biosimilars
Clone Telisotuzumab
Specific against Hu
Appl.
Host
Item no.
Amount 1 mg
Available
Research Grade Abagovomab Login
Type Biosimilars
Clone Abagovomab
Specific against Hu
Appl.
Host Mouse
Item no.
Amount 1 mg
Available
Research Grade Igovomab Login
Type
Clone Igovomab
Specific against Hu
Appl.
Host Mouse
Item no.
Amount 1 mg
Available
Research Grade Oregovomab Login
Type Biosimilars
Clone Oregovomab
Specific against Hu
Appl.
Host Mouse
Item no.
Amount 1 mg
Available
Research Grade Sofituzumab Login
Type Biosimilars
Clone Sofituzumab
Specific against Hu
Appl.
Host
Item no.
Amount 1 mg
Available
Research Grade Demcizumab Login
Type Biosimilars
Clone Demcizumab
Specific against Hu
Appl.
Host
Item no.
Amount 1 mg
Available
Research Grade Enoticumab Login
Type Biosimilars
Clone Enoticumab
Specific against Hu
Appl.
Host Human
Item no.
Amount 1 mg
Available
Research Grade Navicixizumab Login
Type
Clone Navicixizumab
Specific against Hu
Appl.
Host
Item no.
Amount 1 mg
Available
Research Grade Dilpacimab Login
Type
Clone Dilpacimab
Specific against Hu
Appl.
Host
Item no.
Amount 1 mg
Available
Research Grade Farletuzumab Login
Type Biosimilars
Clone Farletuzumab
Specific against Hu
Appl.
Host
Item no.
Amount 1 mg
Available
Research Grade Mirvetuximab Login
Type Biosimilars
Clone Mirvetuximab
Specific against Hu
Appl.
Host
Item no.
Amount 1 mg
Available
Research Grade Indusatumab Login
Type Biosimilars
Clone Indusatumab
Specific against Hu
Appl.
Host Human
Item no.
Amount 1 mg
Available
Research Grade Anetumab Login
Type Biosimilars
Clone Anetumab
Specific against Hu
Appl.
Host Human
Item no.
Amount 1 mg
Available
Research Grade Amatuximab Login
Type Biosimilars
Clone Amatuximab
Specific against Hu
Appl.
Host
Item no.
Amount 1 mg
Available
Research Grade Enapotamab Login
Type Biosimilars
Clone Enapotamab
Specific against Hu
Appl.
Host Human
Item no.
Amount 1 mg
Available
Research Grade Tilvestamab Login
Type Biosimilars
Clone Tilvestamab
Specific against Hu
Appl.
Host
Item no.
Amount 1 mg
Available
Research Grade Pasotuxizumab Login
Type
Clone Pasotuxizumab
Specific against Hu
Appl.
Host
Item no.
Amount 1 mg
Available

16397 Item(s)

per page